Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System?
Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
P2X7 Receptor as a Therapeutic Target.
Different cortical underpinnings for fatigue and depression in MS?
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Albumin and multiple sclerosis.
[Symptoms and neurological findings in patients with multiple sclerosis].
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
Autoimmune neuropathies: insights from animal models.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
673
674
675
676
677
678
679
680
681
…
next ›
last »